Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

R. Rulach; G. G. Hanna; K. Franks; J. McAleese; S. Harrow

doi:10.1016/j.clon.2017.11.003

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

R. Rulach^*, G. G. Hanna, K. Franks, J. McAleese, S. Harrow

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies.

Original language	English
Pages (from-to)	101-109
Number of pages	9
Journal	Clinical Oncology
Volume	30
Issue number	2
Early online date	06 Dec 2017
DOIs	https://doi.org/10.1016/j.clon.2017.11.003
Publication status	Published - Feb 2018

Keywords

Lung cancer
radiotherapy
re-irradiation
retreatment

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clon.2017.11.003Licence: Unspecified

Cite this

@article{6242a977f9434391b3092868364a73f8,

title = "Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits",

abstract = "In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies.",

keywords = "Lung cancer, radiotherapy, re-irradiation, retreatment",

author = "R. Rulach and Hanna, {G. G.} and K. Franks and J. McAleese and S. Harrow",

year = "2018",

month = feb,

doi = "10.1016/j.clon.2017.11.003",

language = "English",

volume = "30",

pages = "101--109",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

AU - Rulach, R.

AU - Hanna, G. G.

AU - Franks, K.

AU - McAleese, J.

AU - Harrow, S.

PY - 2018/2

Y1 - 2018/2

N2 - In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies.

AB - In spite of recent improvements in both the technical delivery of radiotherapy and systemic therapy in the treatment of non-small cell lung cancer, local recurrence rates after radiotherapy remain a significant challenge. In the setting of local relapse after radiotherapy, treatments such as surgical resection or radiofrequency ablation are often not appropriate owing to disease and patient factors. Re-irradiation may be a potential treatment option. This overview considers the published evidence and potential treatment strategies.

KW - Lung cancer

KW - radiotherapy

KW - re-irradiation

KW - retreatment

UR - http://www.scopus.com/inward/record.url?scp=85039846003&partnerID=8YFLogxK

U2 - 10.1016/j.clon.2017.11.003

DO - 10.1016/j.clon.2017.11.003

M3 - Article

AN - SCOPUS:85039846003

VL - 30

SP - 101

EP - 109

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0936-6555

IS - 2

ER -

Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this